Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublimated Mare Milk Supplement in Hepatitis C
NCT03669835Completed
- Sponsor
- Kazakh National Medical University
- Start
- Mar 2018
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Kazakh National Medical University. Primary endpoints: Change in liver function at 8 weeks and Change in urine test at 8 weeks. Started Mar 2018; status: completed.
Beyond the preview
Go deeper on NCT03669835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03669835.